UBS Group AG - MOLECULIN BIOTECH INC ownership

MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 27 filers reported holding MOLECULIN BIOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MOLECULIN BIOTECH INC
ValueSharesWeighting
Q3 2023$85
-99.3%
200
-98.2%
0.00%
Q4 2022$11,918
+8.3%
11,243
+7.7%
0.00%
Q3 2022$11,000
+450.0%
10,444
+531.8%
0.00%
Q2 2022$2,000
-50.0%
1,653
+17.8%
0.00%
Q3 2021$4,0000.0%1,403
+31.0%
0.00%
Q2 2021$4,0001,0710.00%
Other shareholders
MOLECULIN BIOTECH INC shareholders Q2 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,040,529$1,852,0000.61%
Sigma Planning Corp 57,500$102,0000.00%
OSAIC HOLDINGS, INC. 4,233$7,0000.00%
BANK OF AMERICA CORP /DE/ 6,650$12,0000.00%
WELLS FARGO & COMPANY/MN 4,176$7,0000.00%
NORTHERN TRUST CORP 50,731$90,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 245,612$437,0000.00%
STATE STREET CORP 71,397$127,0000.00%
North Star Investment Management Corp. 250$00.00%
View complete list of MOLECULIN BIOTECH INC shareholders